Log in to save to my catalogue

Baicalin inhibits influenza virus A replication via activation of type I IFN signaling by reducing m...

Baicalin inhibits influenza virus A replication via activation of type I IFN signaling by reducing m...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6854550

Baicalin inhibits influenza virus A replication via activation of type I IFN signaling by reducing miR‑146a

About this item

Full title

Baicalin inhibits influenza virus A replication via activation of type I IFN signaling by reducing miR‑146a

Author / Creator

Publisher

Greece: Spandidos Publications

Journal title

Molecular medicine reports, 2019-12, Vol.20 (6), p.5041-5049

Language

English

Formats

Publication information

Publisher

Greece: Spandidos Publications

More information

Scope and Contents

Contents

Influenza virus A (IVA) is one of the predominant causative agents of the seasonal flu and has become an important cause of morbidity worldwide. Great efforts have been paid to develop vaccines against IVA. However, due to antigenic drift in influenza virus A and rapid emergence of drug‑resistant strains, current available vaccines or anti‑IVA chem...

Alternative Titles

Full title

Baicalin inhibits influenza virus A replication via activation of type I IFN signaling by reducing miR‑146a

Authors, Artists and Contributors

Author / Creator

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6854550

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6854550

Other Identifiers

ISSN

1791-2997

E-ISSN

1791-3004

DOI

10.3892/mmr.2019.10743

How to access this item